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ABSTRACT 
Objective:  To test the antibacterial efficacy of leaf, stem, and flower extracts of Albizia julibrissin against bacterial pathogens. 
Methods:  Extraction of active metabolites was carried out by using six different solvents, and total flavonoid content in each extract was 
determined by Aluminium chloride method. To determine the antibacterial activity of extracts, disc diffusion method and tube dilution method were 
carried out. Zone of inhibition and Minimum inhibitory Concentration (MIC) were calculated.  
Results:  Methanolic extracts of leaf samples of A. julibrissin showed highest extractive value (5.14g/100g) and total flavonoid content (35.14mg/g). 
In overall leaf extracts of A. julibrissin showed maximum zone of inhibition towards P. vulgaris (10.1 mm*) and least susceptible microorganism is S. 
typhi (3.5 mm*). Stem and flower extracts inhibited bacterial growth only at higher concentrations (MIC, 160-215 and 65-180µg/ml respectively).  
Conclusion:   Apart from the energy crop, based on the results and value-added compounds present in A. julibrissin, it may be considered as 
antibacterial agent in future. 
Keywords: Albizia julibrissin, Antibacterial, Flavonoids. 
 
INTRODUCTION  
Resistance of bacterial pathogens to antibacterial drugs is a global 
concern. Human infections, particularly affected by antimicrobial 
drug resistance include tuberculosis, malaria, severe acute 
respiratory infections, and sepsis caused by gram-negative bacteria 
[1]. This problem is even more pressing because, in a globalized 
world, there is increasing evidence that particularly persistent, 
relapsing, and difficult-to-treat infections caused by microorganisms 
are associated with either change in their phenotype [2] or genotype 
which, travel faster and farther than even before and the pipeline of 
new drugs is faltering.  
Plants are used traditionally to treat infections in humans or 
animals. But the safety and effectiveness of many plants used in 
traditional medicine by rural people is yet to be evaluated [3]. The 
use of herbal extracts as therapeutic agents for bacterial infections 
may be an interesting area for developing countries and has aroused 
the interest of the population in developed countries [4]. Specifically, 
plants of Albizia genus have been used for several purposes, 
including the treatment of various infections [5] and inflammatory 
pathologies [6].  
Albizia julibrissin Durazz is a leguminous tree which has become an 
excellent energy crop candidate used as biomass feedstock for 
ethanol production [7]. The combination of frost tolerance, nitrogen 
fixation and lack of toxic metabolic compounds are some 
characteristics supporting the adoption of A. julibrissin as an 
agricultural plant [8]. Anti-angiogenic [9] and anti-tumor 
compounds such as terpenoid saponins [10], and julibroside [11] 
occur in A. julibrissin extracts. A. julibrissin foliage also contains 
value-added compounds such as flavonoid glycosides [12], and 
flavonol acyl glycosides [13]. With this in mind and support in 
knowledge of use of A. j.u.librissin in traditional medicine, the 
present study focussed towards successive extraction and 
estimation of flavonoids present in A. j.u.librissin extracts and 
extracts were tested against bacterial pathogens. Leaves, stems, 
flowers and roots of Albizia julibrissin were collected from 
Tiruchengode area, TamilNadu, India and the specimens were 
identified by Botanical survey of India (BSI), Southern circle, 
Coimbatore, India. Hundred grams of dried plant part were 
extracted using a maceration method with six different solvents 
(Petroleum ether, benzene, chloroform, acetone, ethanol, and 
methanol). The overall extractive value was ranged between (1.35 ± 
0.01 to 5.14 ± 0.02 g/100g) and the lowest extractive value was 
observed in benzene and highest value was shown by methanol 
(Table.1). Among plant parts, leaf extracts showed higher extractive 
value than flower (4.26±0.01 g/100g) and stem extracts (3.25±0.01 
g/100g). From the results it was inferred that extractive value of 
solvents increased firstly with an increase in polarity of the solvent, 
but then rapidly decreased with non-polar solvents like petroleum 
ether, benzene and chloroform. Consequently the recovery of active 
constituents with polar solvents like methanol was more than two or 
three times higher as compared to less polar ones. In vitro 
antimicrobial screening of research permits the selection of crude 
plant extracts with potential properties to be used for further 
chemical and pharmaceutical studies [14].  
Total flavonoids in selected plant extracts were determined using 
the aluminum chloride colorimetric method [15]. In A. julibrissin 
extracts, the total flavonoids content in the leaves (35.14 mg/g) was 
higher than the flowers (32.0 mg/g) followed by stem extracts 
(25.26 mg/g). Regardless of the plant part, methanolic extracts 
showed maximum extraction of flavonoids than any other solvent 
used (Table.1). The highest flavonoid content was determined in the 
methanolic extracts followed by ethanol, acetone, petroleum ether, 
chloroform and benzene. Hence methanolic extracts of A. julibrissin 
(Leaf, stem and flower) at different concentrations were tested for 
antibacterial activity. 
Ten different clinical isolates of bacterial pathogens were used for 
this study, which includes Bacillus cereus, Escherichia coli, 
Enterococcus faecalis, Klebsiella pneumonia, Proteus vulgaris, 
Pseudomonas aeruginosa, Salmonella typhi, Salmonella paratyphi, 
Staphylococcus aureus, and Staphylococcus epidermis. Antibacterial 
activity of A. julibrissin extracts was tested by disc diffusion method 
[16] and determination of the Minimum Inhibitory Concentration 
(MIC) [17]. At the least concentration of 50µg/ml leaf extract (Table. 
2) showed antibacterial activity against the gram positive organisms, 
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B. cereus (3.2 mm*) and S. aureus (2.9 mm*) and gram negative 
organisms E. c.o.li (4.7 mm*) and P. aeruginosa (2.1 mm*). The 
evaluation of the antimicrobial activity of leaves, stem and flowers of 
A. julibrissin revealed that total loss of activity at lower 
concentration (50 and 100µg/ml) of stem and flower extracts 
against all the bacteria tested except S. aureus. At higher 
concentration (200µg/ml), leaf and flower extracts were effective 
against all bacterial pathogens tested, and the most susceptible 
microorganism is P. vulagaris (10.1 mm*) and least one is S. typhi 
(3.5 mm*).  
The MIC value of plant extracts showed that among the tested 
clinical pathogens B. cereus, E. coli, E. faecalis and P. vulgaris were 
susceptible to A. julibrissin leaf extracts with MIC values ranging 
from 40-48µg/ml, whereas above species were not easily 
susceptible to A. julibrissin stem extracts (MIC, 150-208µg/ml) (Fig. 
1). Flower extracts were less effective against S. typhi and S. 
paratyphi, generated an MIC of 180 and 165µg/ml respectively. The 
most MICs of stem and flower extracts of A. julibrissin were clustered 
around 150-215µg/ml and 65-180µg/ml respectively. Leaf extracts 
of A. julibrissin showed MIC values ranged between 40-78µg/ml, 
which one is the best antimicrobial agent among the tested extracts. 
MIC results revealed the fact that organisms may need higher 
concentrations of extracts to inhibit growth or kill them and it may 
depend upon their cell wall components. Flavonoids are 
antimicrobial substances, which present in the extracts tested may 
affect the synthesis of peptidoglycan around a bacterial cell;  the cell 
wall may be affected by osmotic shock. [18]. In this study differences 
between the bactericidal activities of plant parts of A. julibrissin 
proposes that changes in the composition of active compounds and 
functional groups may influence the antimicrobial efficacy. 
The need of the hour is to screen a number of medicinal plants for 
promising biological activity. Differences in the antimicrobial effects 
of plant groups might be due to phytochemical properties of the 
selected plant parts. Methanolic extracts of A. julibrissin showed 
higher flavonoid content in plant parts and antibacterial activity, 
which is reported for the first time. But detailed analysis of 
compounds present in each part of the A. julibrissin plant is needed 
for the further usage as an antiseptic agent. 
 
Table 1: Extractive value and flavonoid content of A. julibrissin plant parts 
Solvent  Extractive Value  
(g/100g)* 
Flavonoid content  
(mg/g of extract)* 
Leaf Stem Flower leaf Stem Flower 
Petroleum ether 2.26±0.05 3.23±0.01 1.53±0.01 19.15±0.12 13.70±0.14 16.4±0.12 
Benzene 1.35±0.01 1.43±0.02 1.94±0.15 14.15±0.20 7.63±0.17 10.7±0.17 
Chloroform 3.51±0.04 2.64±0.01 2.56±0.02 16.26±0.18 8.81±0.18 13.7±0.23 
Acetone 3.34±0.02 2.44±0.02 2.81±0.01 21.83±0.15 17.15±0.14 20.2±0.20 
Ethanol 4.52±0.01 3.63±0.02 3.54±0.02 29.11±0.18 19.17±0.14 25.1±0.14 
Methanol  5.14±0.02 3.25±0.01 4.26±0.01 35.14±0.17 25.26±0.20 32.0±0.17 
*Data represents mean± SE of triplicates 
 
Table 2: Antibacterial activity of Albizzia julibrissin by disc diffusion method 
Microorganisms 
 
Zone of Inhibition (mm)* 
Leaf extract  
(microgram) 
Stem extract (microgram) Flower extract (microgram) 
100 200 100 200 100 200 
B. cereus 5.8±0.26 7.4±0.06 - 5.1±0.46 5.1±0.88 6.9±0.78 
E. coli 7.4±0.92 9.1±0.79 - 5.7±0.56 6.2±0.75 8.5±0.82 
E. faecalis 5.2±0.78 6.5±0.08 - 4.1±0.45 4.0±0.57 5.8±0.86 
K. pneumoniae 5.5±0.28 6.9±0.52 - 5.0±0.23 4.8±0.33 6.2±0.48 
P. vulgaris 7.8±0.74 10.1±0.48 - 5.3±0.52 6.1±0.18 8.5±0.56 
P. aeruginosa 4.0±0.78 5.1±0.79 - - 3.1±0.4 4.3±0.95 
S. typhi 2.7±0.45 3.5±0.02 - - - 3.1±0.62 
S. paratyphi 3.3±0.56 5.0±0.74 - - - 4.1±0.28 
S. aureus 5.1±0.09 6.3±0.28 - 4.1±0.43 3.9±0.44 7.1±0.24 
S. epidermis 3.1±0.06 4.2±0.92 - - - 3.5±0.95 
*Data represents mean± SE of triplicates 
 
 
Fig. 1: MIC Value of Albizia julibrissin plant extracts. 
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